Quantification of LVSI Improves Its Strength as Prognostic Factor for Recurrence in Stage I Endometrial Cancer Patients Treated in the PORTEC Trials

Autor:	Jan Willem M. Mens, Carien L. Creutzberg, Vincent T.H.B.M. Smit, Elke E M Peters, Remi A. Nout, Tjalling Bosse, I.M. Jürgenliemk-Schulz, Jan J. Jobsen, Ellen Stelloo
Rok vydání:	2014
Předmět:	Oncology Cancer Research medicine.medical_specialty Prognostic factor Radiation business.industry Internal medicine medicine Radiology Nuclear Medicine and imaging business Stage I endometrial cancer
Zdroj:	International Journal of Radiation Oncology*Biology*Physics. 90:S110-S111
ISSN:	0360-3016
DOI:	10.1016/j.ijrobp.2014.05.531
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8eb1ea9416ac43c4847e6949547feeb6 https://doi.org/10.1016/j.ijrobp.2014.05.531 Zobrazit plný text záznamu